Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001558370-17-000493
Filing Date
2017-02-10
Accepted
2017-02-09 18:19:23
Documents
61
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A immu-20161231x10qa.htm 10-Q/A 44922
2 EXHIBIT 31.1 immu-20161231ex31175e146.htm EX-31.1 15289
3 EXHIBIT 31.2 immu-20161231ex312f005a7.htm EX-31.2 16170
4 EXHIBIT 32.1 immu-20161231ex32115d848.htm EX-32.1 12309
  Complete submission text file 0001558370-17-000493.txt   4803144

Data Files

Seq Description Document Type Size
5 immu-20161231.xml EX-101.INS 1482886
6 immu-20161231.xsd EX-101.SCH 36082
7 immu-20161231_cal.xml EX-101.CAL 44734
8 immu-20161231_def.xml EX-101.DEF 140456
9 immu-20161231_lab.xml EX-101.LAB 342251
10 immu-20161231_pre.xml EX-101.PRE 289334
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q/A | Act: 34 | File No.: 000-12104 | Film No.: 17588903
SIC: 2835 In Vitro & In Vivo Diagnostic Substances